Detalhe da pesquisa
1.
Population pharmacokinetic modelling of tremelimumab in patients with advanced solid tumours and the impact of disease status on time-varying clearance.
Br J Clin Pharmacol
; 89(5): 1601-1616, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36454221
2.
Safety, tolerability, and pharmacokinetics of half-life extended SARS-CoV-2-neutralizing monoclonal antibodies AZD7442 (tixagevimab/cilgavimab) in healthy Japanese adults.
J Infect Chemother
; 29(11): 1061-1067, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37524201
3.
Safety, Tolerability, and Pharmacokinetics of Benralizumab: A Phase 1, Randomized, Single-Blind Study of Healthy Chinese Participants.
Drug Des Devel Ther
; 17: 209-218, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36726737
4.
A new method for identification of outliers in immunogenicity assay cut point data.
J Immunol Methods
; 484-485: 112817, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32615125
5.
Efficacy and Tolerability of Tremelimumab in Locally Advanced or Metastatic Urothelial Carcinoma Patients Who Have Failed First-Line Platinum-Based Chemotherapy.
Clin Cancer Res
; 26(1): 61-70, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31801732